DNA immunization with recombinant HCV E2 expression plasmids

Acta Biochimica et Biophysica Sinica

Volumn 34, Issue 4, 2002, Pages 445-451

  Zhu, Jun ^a   Wang, Chun Lin ^a   Zhu, Li Xin ^a   Kong, Yu Ying ^a   Wang, Yuan ^a   Li, Guang Di ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

DNA vaccine; HBV preS1; HCV E2; Promoter; Signal sequence

Indexed keywords

CYTOKINE; DNA VACCINE; LIVE VACCINE; PEPTIDE DERIVATIVE; PRES1[21-47]; PROTEIN ANTIBODY; PROTEIN E2; PROTEIN S1E2T660; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE TARGETING; HELA CELL; HEPATITIS C VIRUS; IMMUNE RESPONSE; IMMUNIZATION; INOCULATION; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; RECOMBINANT PLASMID; VACCINATION;

ANIMALS; ANTIBODIES; FEMALE; HELA CELLS; HUMANS; MICE; MICE, INBRED C57BL; PLASMIDS; RECOMBINANT FUSION PROTEINS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 0036401055     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Tanghe A, Lefevre P, Denis O, D'souza S, Braibant M, Lozes E, Singh M et al. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol, 1999, 162(2): 1113-1119
2. Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA, 1993, 90(9): 4156-4160
3. Michel ML, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen RG. DNA-mediated immunization to the hepatitis B surface antigen in mice: Aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA, 1995, 92(12): 5307-5311
4. Cox GJ, Zamb TJ, Babiuk LA. Bovine herpesvirus immune responses in mice and cattle injected with plasmid DNA. J Virol, 1993, 67(9): 5664-5667
5. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science, 1993, 259(5102): 1745-1749
6. Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology, 1994, 199(1): 132-140
7. Letvin NL, Montefiori DC, Yasutomi Y, Perry HC, Davies ME, Lekutis C, Alroy M et al. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA, 1997, 94(17): 9378-9383
8. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med, 1998, 4(4): 397-402
9. Pancholi P, Liu Q, Tricoche N, Zhang P, Perkus ME, Prince AM. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins. J Infect Dis, 2000, 182(1): 18-27
10. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA, 1993, 90(24): 11478-11482
11. Major ME, Vitvitski L, Mink MA, Schleef M, Whalen RG, Trepo C, Inchauspe G. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol, 1995, 69(9): 5798-5805
12. Lee SW, Cho JH, Sung YC. Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene. J Virol, 1998, 72(10): 8430-8436
13. Song MK, Lee SW, Suh YS, Lee KJ, Sung YC. Enhancement of immunoglobulin G2α and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice. J Virol, 2000, 74(6): 2920-2925
14. Choo Q L, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, Han J et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA, 1994, 91 (4): 1294-1298
15. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA, 1996, 93(5): 1759-1763
16. Zhu J, Kong YY, Liu J, Zhang ZC, Wang Y, Li GD. Secretory expression of different C-terminal truncated HCV E1 proteins in mammalian cells and characterization of the expressed products. Acta Biochim Biophys Sin, 2001, 33(6): 634-640
17. Wang CL, Zhu LX, Liu J, Zhang ZC, Wang Y, Li GD. Expression and characterization of hepatitis C virus E2 glycoprotein fused to hepatitis B virus preS1 (21-47) fragment in CHO cells. Acta Biochim Biophys Sin, 2002, 34(4): 400-404
18. Wang Y, Okamoto H, Tsuda F, Nagayama R, Tao QM, Mishiro S. Prevalence, genotypes and isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol, 1993, 40(3): 254-260
19. Hui JY, Li GD, Kong YY, Wang Y. DNA-based immunization against hepatitis B surface antigen preS epitopes. Chinese Sci Bull, 1999, 44(2): 620-623
20. Yang HL, Jin Y, Cao HT, Xu X, Li GD, Wang Y, Zhang ZC. Affinity purification of hepatitis B virus surface antigen containing preS1 region. Acta Biochim Biophys Sin, 1996, 28(4): 412-417
21. Liu J, Zhu L, Zhang X, Lu M, Kong Y, Wang Y, Li G, Expression, purification, immunological characterization and application of Escherichia coli-derived hepatitis C virus E2 proteins. Biotechnol Appl Biochem, 2001, 34(2): 109-119
22. Wei J, Liu XJ, Li GD, Wang Y, Zhang ZC, Wang YQ, Lu ZM. Expression, purification and preliminary clinical use of recombinant HBsAg GST-preS1 (21-47 aa) fusion proteins. Acta Biochim Biophys Sin, 2001, 33(4): 379-385